-
ANI launches generic Nilandron
BAUDETTE, Minn. — ANI Pharmaceuticals on Monday announced the immediate launch of its generic of Nilandron (nilutamide) tablets following the Food and Drug Administration’s approval of the drug. This is the first generic of the drug, which is indicated to treat metastatic prostate cancer in combination with surgical castration.Nilandron had trailing 12-month sales of $23 million according to IMS Health.Dr. Reddy’s launches generic Zegerid
HYDERABAD, India and PRINCETON, N.J. — Dr. Reddy’s Laboratories on Monday announced the launch of its generic Zegerid (omeprazole/sodium bicarbonate).The drug had U.S. sales of about $306.7 million for the 12 months ended May 2016, according to IMS Health. Dr. Reddy’s generic will be available in two dosage strengths: 20 mg omeprazole/1100 mg sodium bicarbonate and 40 mg omeprazole/1100 mg sodium bicarbonate.